Moneta Group Investment Advisors LLC Vista Gen Therapeutics, Inc. Transaction History

Moneta Group Investment Advisors LLC

  • $9.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.12 - $0.3 $6,081 - $15,204
50,682 New
50,682 $6,000
Q3 2022

Nov 14, 2022
BUY
$0.14 - $4.8 $7,045 - $241,555
50,324 Added 2213.99%
52,597 $8,000
Q2 2022

Aug 15, 2022
BUY
$0.88 - $1.73 $2,000 - $3,932
2,273 New
2,273 $2,000

Others Institutions Holding VTGN

# of Institutions
1
Shares Held
27.1K
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $610M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email